(Q46040109)

English

A haplotype of the norepinephrine transporter (Net) gene Slc6a2 is associated with clinical response to atomoxetine in attention-deficit hyperactivity disorder (ADHD).

scientific article published on 22 April 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/19387424

A haplotype of the norepinephrine transporter (Net) gene Slc6a2 is associated with clinical response to atomoxetine in attention-deficit hyperactivity disorder (ADHD). (English)

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/19387424

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Diane Purper-Ouakil

object named as

Diane Purper-Ouakil

9

0 references

object named as

Nicolas Ramoz

1

0 references

object named as

Philip Gorwood

10

0 references

author name string

Claudette Boni

2

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/19387424

Anncatherine M Downing

3

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/19387424

Sandra L Close

4

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/19387424

Sandra L Peters

5

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/19387424

Angela M Prokop

6

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/19387424

Albert J Allen

7

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/19387424

Michel Hamon

8

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/19387424

language of work or name

0 references

publication date

22 April 2009

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/19387424

Neuropsychopharmacology

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/19387424

34

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/19387424

9

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/19387424

2135-2142

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/19387424

https://scigraph.springernature.com/pub.10.1038/npp.2009.39

0 references

The norepinephrine transporter gene and attention-deficit hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.39

21 January 2018

Haploview: analysis and visualization of LD and haplotype maps

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.39

21 January 2018

Attention-deficit/hyperactivity disorder (ADHD) as a noradrenergic disorder

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.39

21 January 2018

The analysis of 51 genes in DSM-IV combined type attention deficit hyperactivity disorder: association signals in DRD4, DAT1 and 16 other genes

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.39

21 January 2018

No evidence of linkage or association between the norepinephrine transporter (NET) gene MnlI polymorphism and adult ADHD.

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.39

21 January 2018

Molecular genetics of attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.39

21 January 2018

The structure of haplotype blocks in the human genome

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.39

21 January 2018

Association of the dopamine receptor D4 (DRD4) gene 7-repeat allele with children with attention-deficit/hyperactivity disorder (ADHD): an update

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.39

21 January 2018

Once-daily atomoxetine treatment for children with attention-deficit/hyperactivity disorder, including an assessment of evening and morning behavior: a double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.39

21 January 2018

Catechol-O-methyltransferase Val158Met polymorphism is associated with methylphenidate response in ADHD children.

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.39

21 January 2018

Further evidence of association between two NET single-nucleotide polymorphisms with ADHD

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.39

21 January 2018

Pharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug response

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.39

21 January 2018

Response to methylphenidate in adults with ADHD is associated with a polymorphism in SLC6A3 (DAT1).

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.39

21 January 2018

No evidence of linkage or association between the norepinephrine transporter (NET) gene polymorphisms and ADHD in the Irish population

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.39

21 January 2018

Once-daily atomoxetine treatment for children and adolescents with attention deficit hyperactivity disorder: a randomized, placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.39

21 January 2018

Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.39

21 January 2018

Relapse prevention in pediatric patients with ADHD treated with atomoxetine: a randomized, double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.39

21 January 2018

Atomoxetine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, dose-response study

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.39

21 January 2018

CYP2D6 and clinical response to atomoxetine in children and adolescents with ADHD.

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.39

21 January 2018

Genome-wide association study of response to methylphenidate in 187 children with attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.39

21 January 2018

Atomoxetine and osmotically released methylphenidate for the treatment of attention deficit hyperactivity disorder: acute comparison and differential response.

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.39

21 January 2018

Association of the adrenergic alpha2A receptor gene with methylphenidate improvement of inattentive symptoms in children and adolescents with attention-deficit/hyperactivity disorder.

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.39

21 January 2018

Attention-deficit/hyperactivity disorder: advancing on pharmacogenomics

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.39

21 January 2018

Polymorphisms of the dopamine D4 receptor, clinical outcome, and cortical structure in attention-deficit/hyperactivity disorder.

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.39

21 January 2018

Familial clustering of symptoms and disruptive behaviors in multiplex families with attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.39

21 January 2018

Refining the attention deficit hyperactivity disorder phenotype for molecular genetic studies

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.39

21 January 2018

The clinical role of genetic polymorphisms in drug-metabolizing enzymes

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.39

21 January 2018

Etiology of inattention and hyperactivity/impulsivity in a community sample of twins with learning difficulties.

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.39

21 January 2018

Association of norepinephrine transporter gene with methylphenidate response

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.39

21 January 2018

Partial Replication of a DRD4 Association in ADHD Individuals Using a Statistically Derived Quantitative Trait for ADHD in a Family-Based Association Test

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.39

21 January 2018

Validity of DSM-IV subtypes of attention-deficit/hyperactivity disorder: a family study perspective

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.39

7 January 2021

based on heuristic

inferred from DOI database lookup

Latent class and factor analysis of DSM-IV ADHD: a twin study of female adolescents

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.39

7 January 2021

based on heuristic

inferred from DOI database lookup

Attention-deficit hyperactivity disorder: a category or a continuum? Genetic analysis of a large-scale twin study

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.39

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/NPP.2009.39

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/19387424

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/19387424

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46040109&oldid=1510738052"